116 related articles for article (PubMed ID: 30995524)
21. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
[TBL] [Abstract][Full Text] [Related]
22. Stromal cartilage oligomeric matrix protein as a tumorigenic driver in ovarian cancer via Notch3 signaling and epithelial-to-mesenchymal transition.
Gorji-Bahri G; Krishna BM; Hagerling C; Orimo A; Jirström K; Papadakos KS; Blom AM
J Transl Med; 2024 Apr; 22(1):351. PubMed ID: 38615020
[TBL] [Abstract][Full Text] [Related]
23. Incomplete B cell tolerance to cartilage oligomeric matrix protein in mice.
Geng H; Nandakumar KS; Xiong L; Jie R; Dong J; Holmdahl R
Arthritis Rheum; 2013 Sep; 65(9):2301-9. PubMed ID: 23754310
[TBL] [Abstract][Full Text] [Related]
24. Serum cartilage oligomeric matrix protein (COMP) expression in individuals who sustained a youth sport-related intra-articular knee injury 3-10 years previously and uninjured matched controls.
Laudon J; Whittaker JL; Ren G; Jaremko JL; Emery CA; Krawetz RJ
Osteoarthritis Cartilage; 2019 Feb; 27(2):286-293. PubMed ID: 30317002
[TBL] [Abstract][Full Text] [Related]
25. Cartilage oligomeric protein, matrix metalloproteinase-3, and Coll2-1 as serum biomarkers in knee osteoarthritis: a cross-sectional study.
Georgiev T; Ivanova M; Kopchev A; Velikova T; Miloshov A; Kurteva E; Yuzeir K; Penkov M; Kabakchieva P; Rashkov R; Stoilov R
Rheumatol Int; 2018 May; 38(5):821-830. PubMed ID: 29164307
[TBL] [Abstract][Full Text] [Related]
26. Effects of cartilage oligomeric matrix protein on bone morphogenetic protein-2-induced differentiation of mesenchymal stem cells.
Guo P; Shi ZL; Liu A; Lin T; Bi F; Shi M; Yan SG
Orthop Surg; 2014 Nov; 6(4):280-7. PubMed ID: 25430711
[TBL] [Abstract][Full Text] [Related]
27. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury.
Kühne SA; Neidhart M; Everson MP; Häntzschel H; Fine PR; Gay S; Häuselmann HJ; Gay RE
Rheumatol Int; 1998; 18(1):21-5. PubMed ID: 9672995
[TBL] [Abstract][Full Text] [Related]
28. Cartilage oligomeric matrix protein (COMP)-mediated cell differentiation to proteolysis mechanism networks from human normal adjacent tissues to lung adenocarcinoma.
Wang L; Huang J; Jiang M; Diao H; Zhou H; Li X; Chen Q; Jiang Z; Feng H; Wolfl S
Anal Cell Pathol (Amst); 2013; 36(3-4):93-105. PubMed ID: 24064399
[TBL] [Abstract][Full Text] [Related]
29. Cartilage Oligomeric Matrix Protein initiates cancer stem cells through activation of Jagged1-Notch3 signaling.
Papadakos KS; Bartoschek M; Rodriguez C; Gialeli C; Jin SB; Lendahl U; Pietras K; Blom AM
Matrix Biol; 2019 Aug; 81():107-121. PubMed ID: 30502484
[TBL] [Abstract][Full Text] [Related]
30. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
[TBL] [Abstract][Full Text] [Related]
31. COMP serum levels: A new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis.
Zachou K; Gabeta S; Shums Z; Gatselis NK; Koukoulis GK; Norman GL; Dalekos GN
Eur J Intern Med; 2017 Mar; 38():83-88. PubMed ID: 28100410
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of DC-SIGN and DC-SIGNR, which are novel markers expressed in human colon cancer.
Jiang Y; Zhang C; Chen K; Chen Z; Sun Z; Zhang Z; Ding D; Ren S; Zuo Y
PLoS One; 2014; 9(12):e114748. PubMed ID: 25504222
[TBL] [Abstract][Full Text] [Related]
33. Cartilage oligomeric matrix protein: a new promising biomarker of liver fibrosis in chronic hepatitis C.
Andréasson K; Hesselstrand R; Saxne T; Holmberg A; Norrgren H; Jönsson G
Infect Dis (Lond); 2015; 47(12):915-8. PubMed ID: 26269256
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis.
Vilím V; Olejárová M; Machácek S; Gatterová J; Kraus VB; Pavelka K
Osteoarthritis Cartilage; 2002 Sep; 10(9):707-13. PubMed ID: 12202123
[TBL] [Abstract][Full Text] [Related]
35. Comparison of protein immunoprecipitation-multiple reaction monitoring with ELISA for assay of biomarker candidates in plasma.
Lin D; Alborn WE; Slebos RJ; Liebler DC
J Proteome Res; 2013 Dec; 12(12):5996-6003. PubMed ID: 24224610
[TBL] [Abstract][Full Text] [Related]
36. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
[TBL] [Abstract][Full Text] [Related]
37. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
[TBL] [Abstract][Full Text] [Related]
38. The early diagnostic value of serum neopterin and cartilage oligomeric matrix protein for osteoarticular changes among brucellosis patients at an early period.
Zhao ZJ; Li Q; Ma L; Li JQ; Xu LQ
J Orthop Surg Res; 2018 Sep; 13(1):222. PubMed ID: 30180854
[TBL] [Abstract][Full Text] [Related]
39. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
Verma P; Dalal K
J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
[TBL] [Abstract][Full Text] [Related]
40. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
